Trial Profile
A prospective study to investigate pharmacokinetics of topical and intravitreal Bevacizumab in adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Bevacizumab (Primary)
- Indications Corneal disorders
- Focus Pharmacokinetics
- 05 Dec 2015 New trial record